Prise en charge ambulatoire de la pneumonie acquise à domicile de l'adulte. Partie II: stratégie thérapeutique et du suivi. [Ambulatory management of community-acquired pneumonia in the adult. II: Therapeutic strategy and follow-up]
Détails
ID Serval
serval:BIB_A6205B90768B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Prise en charge ambulatoire de la pneumonie acquise à domicile de l'adulte. Partie II: stratégie thérapeutique et du suivi. [Ambulatory management of community-acquired pneumonia in the adult. II: Therapeutic strategy and follow-up]
Périodique
Schweizerische Rundschau fur Medizin Praxis
ISSN
1013-2058 (Print)
Statut éditorial
Publié
Date de publication
11/2002
Volume
91
Numéro
45
Pages
1915-20
Notes
English Abstract Journal Article --- Old month value: Nov 6
Résumé
In adult outpatients with community-acquired pneumonia, the choice for antibiotherapy is empirical. This choice includes the age and the severity assessment of the patient, and the epidemiology of respiratory pathogens. New fluoroquinolones are not recommended as first line agents. Patients with community-acquired pneumonia had an increased morbidity and mortality. Prevention includes influenza and pneumococcal vaccination, and smoking cessation.
Mots-clé
Adult Aged *Ambulatory Care Anti-Bacterial Agents/adverse effects/*therapeutic use Community-Acquired Infections/*drug therapy/mortality/prevention & control Female Humans Influenza Vaccines/administration & dosage Male Microbial Sensitivity Tests Middle Aged Pneumococcal Vaccines/administration & dosage Pneumonia, Bacterial/*drug therapy/mortality/prevention & control Smoking Cessation Survival Rate
Pubmed
Création de la notice
25/01/2008 14:55
Dernière modification de la notice
20/08/2019 16:11
Données d'usage
